Author's Reply: Fecal Occult Blood Testing

The Authors’ Reply

Diagnostic testing following fecal occult blood screening in the elderly.

BACKGROUND Screening with a fecal occult blood test (FOBT) has been shown to reduce colorectal cancer mortality in controlled trials. Recently, Medicare approved payment for FOBT screening. We evaluated the pattern of diagnostic testing following the initial FOBT in elderly Medicare beneficiaries. Such follow-up testing would in the long run influence both the cost and the benefit of widespread...

Screening for colorectal cancer with fecal occult blood testing.

153 SCREENING FOR COLORECTAL CANCER WITH FECAL OCCULT BLOOD TESTING AND COLONOSCOPY: CORRELATION OF CLINICAL DATA, SITE, SIZE AND DISEASE’S STAGE Iuliana Taraşi, Gabriela Florenţa Dumitrescu, Anca Indrei, P. Plămădeală, Anca Trifan, C. Stanciu, 1 Departament of Gastroenterology, „St. Spiridon” Emergency Clinical Hospital Iaşi 2 Department of Pathology, „Prof. Dr. N. Oblu” Emergency Clinical Hos...

Fecal occult blood testing remains a valuable screening tool.

Both colonoscopy and FOBT are options for CRC screening. For those at an average risk of developing CRC, screening should start at age 50 years. The 2 screening options most often selected are colonoscopy every 10 years and annual FOBT. While FOBT is noninvasive, if a positive result is found, then a colonoscopy is recommended. Over the course of multiple years of screening, false-positive FOBT...

Fecal occult blood testing and the incidence of colorectal cancer.

OBJECTIVE The objective of this abstract is to demonstrate by life table methodology a significant reduction in the mean annual incidence rate of colorectal cancer in randomized groups with annual or biennial screening for fecal occult blood, as compared with the annual incidence rate in the control group. BACKGROUND Testing for the presence of fecal occult blood has long been used for the ea...